Markus Krumme Novartis

Markus Krumme is Head of the Continuous Manufacturing Unit in Novartis’ Technical R&D since June 1st, 2011. During his career at Novartis, Markus Krumme has had the responsibility to conceive and implement the Continuous Manufacturing Technology and first plant on the Basel Campus. He is the industrial Co-Director of the Novartis-MIT Center for Continuous Manufacturing.

Prior to joining Novartis, Markus Krumme worked for Lohmann Therapy Systems for 13 years in leading roles in Research and Development in the US and Germany, including Vice President Research and Development. Prior to LTS Markus worked as a lecturer at the University of Tuebingen, Germany, in Pharmaceutical Technology.

Markus is a licensed pharmacist in Germany and has a PhD in Pharmaceutical Technology from the Free University Berlin. His professional focus comprises the total integration of process chains across chemical and pharmaceutical operations covering technical, quality and regulatory aspects, with past profound experience in solid dosage forms, oral and transdermal.